Pfizer Begins Trial of COVID Drug Paxlovid in Kids 6 to 17

WEDNESDAY, March 9, 2022 -- Pfizer Inc. announced Tuesday that it has launched a Phase 2/3 clinical trial of its COVID antiviral pill known as Paxlovid in children ages 6-17.

A news release from the company said the trial will assess the safety and...